We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$25.3B
AUM Growth
+$814M
Cap. Flow
+$613M
Cap. Flow %
2.42%
Top 10 Hldgs %
16.08%
Holding
3,081
New
5
Increased
1,358
Reduced
932
Closed
769

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$31.9M
2
AAPL icon
Apple
AAPL
+$24.9M
3
T icon
AT&T
T
+$21.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$20.2M
5
BIIB icon
Biogen
BIIB
+$19.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$34M
2
RHT
Red Hat Inc
RHT
+$22.2M
3
HSBC icon
HSBC
HSBC
+$20.3M
4
APC
Anadarko Petroleum
APC
+$19.9M
5
CAJ
Canon, Inc.
CAJ
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 16.76%
3 Healthcare 12.56%
4 Consumer Discretionary 10.05%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVH icon
2251
Evolent Health
EVH
$341M
$88K ﹤0.01%
12,272
+7,183
+141% +$51.5K
MNK
2252
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$88K ﹤0.01%
36,446
-87,394
-71% -$446K
CBAY
2253
DELISTED
Cymabay Therapeutics
CBAY
$87K ﹤0.01%
16,861
+2,325
+16% +$14.1K
PDS
2254
Precision Drilling
PDS
$1B
$86K ﹤0.01%
3,765
+1,372
+57% +$40K
EGO icon
2255
Eldorado Gold
EGO
$7.89B
$83K ﹤0.01%
10,685
-1,573
-13% -$12.8K
CTMX icon
2256
CytomX Therapeutics
CTMX
$675M
$79K ﹤0.01%
10,678
+4,406
+70% +$43.5K
IPI icon
2257
Intrepid Potash
IPI
$458M
$79K ﹤0.01%
2,429
-557
-19% -$18.6K
UNT
2258
DELISTED
UNIT Corporation
UNT
$77K ﹤0.01%
22,692
-52,021
-70% -$256K
ADT icon
2259
ADT
ADT
$5.61B
$76K ﹤0.01%
12,046
+2,520
+26% +$14.3K
HIMX
2260
Himax Technologies
HIMX
$2.21B
$75K ﹤0.01%
33,102
-8,219
-20% -$21.5K
GRPN icon
2261
Groupon
GRPN
$1.06B
$74K ﹤0.01%
1,386
-981
-41% -$57.7K
NOG icon
2262
Northern Oil and Gas
NOG
$2.29B
$73K ﹤0.01%
3,714
+2,125
+134% +$39K
JCP
2263
DELISTED
J.C. Penney Company, Inc.
JCP
$72K ﹤0.01%
80,938
-66,688
-45% -$56K
AMRX icon
2264
Amneal Pharmaceuticals
AMRX
$5.83B
$71K ﹤0.01%
24,416
+12,083
+98% +$42.2K
RAD
2265
DELISTED
Rite Aid Corporation
RAD
$70K ﹤0.01%
10,085
-1,329
-12% -$9.54K
AHT
2266
Ashford Hospitality Trust
AHT
$20.9M
$69K ﹤0.01%
21
-12
-36% -$33.5K
PGEN icon
2267
Precigen
PGEN
$2.22B
$67K ﹤0.01%
11,725
-550
-4% -$3.74K
WOW
2268
DELISTED
WideOpenWest
WOW
$66K ﹤0.01%
10,651
+7,921
+290% +$51.6K
ONIT
2269
Onity Group
ONIT
$308M
$66K ﹤0.01%
2,358
-146
-6% -$4.08K
HMHC
2270
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$65K ﹤0.01%
12,234
+5,129
+72% +$29K
VSI
2271
DELISTED
Vitamin Shoppe Inc.
VSI
$65K ﹤0.01%
10,023
-148
-1% -$831
WT icon
2272
WisdomTree
WT
$2.95B
$62K ﹤0.01%
11,893
+5,738
+93% +$32.4K
GLUU
2273
DELISTED
Glu Mobile Inc.
GLUU
$62K ﹤0.01%
12,358
+4,506
+57% +$25.8K
RIGL icon
2274
Rigel Pharmaceuticals
RIGL
$682M
$60K ﹤0.01%
3,191
+2,567
+411% +$53K
ATRS
2275
DELISTED
Antares Pharma, Inc.
ATRS
$60K ﹤0.01%
17,791
+3,392
+24% +$11.2K
89 90
91
92 93

Similar funds

OU
Optiver US Chicago, Illinois $50B AUM 53.51% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return

Aperio Group's Q3 2019 Portfolio in Review

As of Q3 2019, Aperio Group held 3,081 positions worth $25.3B, up 3.3% from $24.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q3 2019 filing shows 5 new, 1,358 increased, 932 reduced and 769 closed positions. Its largest new stake was Genmab: 211,272 shares worth $4.28M. The largest sale was Pfizer, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q3 2019 buy was Genmab: 211,272 shares worth $4.28M.
  • Aperio Group added most to Microsoft in Q3 2019, an estimated $31.9M increase.
  • Aperio Group's biggest Q3 2019 reduction was Pfizer, cutting an estimated $34M.
  • Aperio Group fully exited Red Hat Inc in Q3 2019, selling an estimated $22.2M.
  • Aperio Group's ten largest holdings make up 16% of its $25.3B portfolio in Q3 2019.
  • Aperio Group opened 5 new positions and closed 769 in Q3 2019.
  • Aperio Group's portfolio value rose 3.3% quarter-over-quarter to $25.3B.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.